Beta-amanitin
|
WikiDoc Resources for Beta-amanitin |
|
Articles |
|---|
|
Most recent articles on Beta-amanitin Most cited articles on Beta-amanitin |
|
Media |
|
Powerpoint slides on Beta-amanitin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Beta-amanitin at Clinical Trials.gov Trial results on Beta-amanitin Clinical Trials on Beta-amanitin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Beta-amanitin NICE Guidance on Beta-amanitin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Beta-amanitin Discussion groups on Beta-amanitin Patient Handouts on Beta-amanitin Directions to Hospitals Treating Beta-amanitin Risk calculators and risk factors for Beta-amanitin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Beta-amanitin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Beta-amanitin or β-amanitin is a cyclic nonribosomal peptide of eight amino acids. It is an amatoxin, a group of toxins isolated from and found in in several members of the Amanita genus of mushrooms, one being the Death cap (Amanita phalloides) as well as the Destroying angel, a complex of similar species, principally A. virosa and A. bisporiga.